Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.
Kathryn Cecilia Arbour, MD
Advertisement
Articles by Kathryn Cecilia Arbour, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
2
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma
3
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
4
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer
5